Aim: The present study aimed to: (i) examine the reliability and validity of the Dementia Assessment Sheet for Community-based Integrated Care System 21-items for classifying patients to the appropriate categories for glycemic targets in older patients; and (ii) develop a short version of the tool and examine its reliability and validity.
Introduction
Approximately 300 million older patients worldwide have diabetes. The incidence of diabetes is also rapidly increasing in Japan because of the growing aging population and lifestyle changes. 1 Hypoglycemia is more harmful in patients with limited life expectancy, such as those who are frail or with severe dementia; thus, intensive glycemic control might be unsuitable for these patients. [2] [3] [4] The American Diabetes Association has emphasized a patient-centered approach in diabetes management; that is, individualized therapeutic decisions based on ethnicity, overall risk for atherosclerotic cardiovascular disease, life expectancy, comorbidities, patient's preference and goals and their ability to adhere to treatment regimens. 5, 6 Cognitive and functional status is highly associated with life expectancy and treatment adherence. The American Diabetes Association/American Geriatrics Society Consensus report 7 and the International Diabetes Federation's Global Guideline 8 recommended that the glycemic target of older patients with diabetes mellitus should be individualized based on cognitive and functional status, comorbidities, and life expectancy. The Japan Diabetes Society/Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with Diabetes released the "Glycemic targets for elderly patients with diabetes mellitus" guideline in 2016. In this directive, physicians are recommended to determine the glycemic target based on cognitive functions, activities of daily living (ADL) and comorbidities. [9] [10] [11] However, the assessment of cognitive functions and ADL using multiple conventional scales, such as the Mini-Mental State Examination (MMSE), the Barthel index and Lawton instrumental ADL (IADL) scale, is time-consuming and requires a number of personnel in the clinical setting. Thus, the development of a simple tool for simultaneous assessment of both cognitive and daily functions is of great importance. The Dementia Assessment Sheet for Community-based Integrated Care System 21-items (DASC-21; Appendix S1) was originally developed as a simple assessment tool for cognitive function in community-dwelling people in Japan. The DASC-21 was confirmed to be a valid and reliable tool for evaluating cognitive impairment and ADL disabilities. 12 Because the DASC-21 includes questions about the IADL, basic ADL (BADL) and cognition, it can be useful in classifying older patients with diabetes mellitus to the appropriate category for the glycemic target.
Therefore, we had two aims in the present study: first was to examine the reliability and validity of the DASC-21 in classifying patients into the appropriate category for determining the glycemic targets in older patients; and second, to develop a short version of the DASC-21 (i.e. DASC-8), and also examine its reliability and validity.
Methods

Participants and study design
The present multicenter cross-sectional study recruited 410 older individuals (157 men, 253 women; mean age 79.9 AE 6.7 years) from Tokyo Metropolitan Geriatric Hospital (n = 23), Kanazawa Medical University Hospital (n = 227), the University of Tokyo Hospital (n = 72), Chiba University Hospital (n = 17), Nagoya University Hospital (n = 7), Osaka University Hospital (n = 40), and Tokyo Medical and Dental University Medical Hospital (n = 24). Among the participants, 70 had diabetes mellitus. All the participants were asked to answer questionnaires regarding BADL, IADL and medical history. BADL, IADL and cognitive functions were assessed using the Barthel Index, 13 the Lawton IADL scale 14 and the MMSE, 15 respectively.
DASC-21
BADL, IADL and cognitive functions of the participants were also measured using the DASC-21. The DASC-21 consists of 21 items categorized into three domains: cognitive functions (9 items), IADL (6 items) and BADL (6 items); Appendix S1. The items are rated on a 4-point Likert scale from 1 ("intact") to 4 ("severe impairment"), with the total score ranging from 21 to 84. High scores indicate poor functions.
Categories for determining glycemic targets for older patients with diabetes
The categories for determining the glycemic targets for older patients with diabetes were operationally defined using the MMSE, the Barthel index and the Lawton IADL scale to assess cognitive functions, BADL and IADL, respectively. In classifying cognitive functions, we defined an MMSE score of ≥24 as intact, 18-23 as mildly impaired and ≤17 as moderately-to-severely impaired. In classifying the BADL, we defined the Barthel Index score of ≥80 as intact and <80 as impaired. In classifying IADL, we defined the Lawton IADL score of 5, common to both men and women, as intact and <5 as impaired. Based on the assessment of cognitive functions, IADL and BADL, the patients were divided into three categories for determining the glycemic target in older patients with diabetes stipulated by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with Diabetes. Patients were classified into categories according to their cognitive functions, IADL and BADL as follows: category I, those with intact cognitive functions and no ADL impairment; category II, those with mild cognitive impairment to mild dementia and/or impairment(s) of IADL with no impairment of BADL; and category III, those with moderate or severe dementia and/or impairment(s) of BADL and/or the presence of multiple comorbidities or functional impairments.
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Statistical analysis
Continuous variables with normal distribution, such as age, were presented as mean AE standard deviation. One-way ANOVA and Welch's t-test was used to compare these variables between each category. Non-normal distributions, such as the Lawton IADL score, were presented as the median and range. Kruskal-Wallis one-way analysis and Mann-Whitney U-test were used for nonparametric comparisons, and the χ 2 -test was used for categorical variables. A P-value <0.05 was considered to show significance.
To develop the DASC-8, an exploratory factor analysis using the maximum likelihood estimation with a promax rotation was carried out. Cronbach's alpha coefficients were calculated to examine internal reliability. Receiver operating characteristic (ROC) analyses were used to evaluate the discriminatory capability of the DASC-21 and the DASC-8 for classifying the patients into the appropriate category, and to determine the optimal DASC-21 and DASC-8 cut-off scores for classification of the category.
Spearman's correlation coefficients were used to confirm the correlation between the DASC-21 or DASC-8 and the MMSE, the Lawton IADL score or the Barthel Index score. Multiple logistic regression analyses were used to examine the strength of the association between the classification of category by the DASC score, and the category defined using the scores of the MMSE, Lawton IADL scale and Barthel Index as outcome variables after controlling for age and sex. All statistical analyses were carried out using SPSS version 22 (SPSS, Chicago, IL, USA) and R version 3.4.1. (R Core Team, Vienna, Austria).
Ethics
The present study was carried out in accordance with the Declaration of Helsinki, and the protocol was approved by the ethics committees of the Tokyo Metropolitan Geriatric Hospital (R16-33) and the other institutions. Written informed consent was obtained from all participants or their family member and other supportive adult if cognitive function was severely impaired. 
Results
Participant characteristics
Reliability and discriminant validity of the DASC-21
The Cronbach's alpha of the DASC-21 was 0.965. The DASC-21 strongly correlated with the MMSE score (r = −0.722, P < 0.001), Lawton IADL score (r = −0.851, P < 0.001) and Barthel Index score (r = −0.641, P < 0.001).
For the discrimination of category I from II or III, the ROC analyses showed that the area under the curve (AUC) was 0.918 (95% CI 0.892-0.944). When using a cut-off point of 26 out of 27 for DASC-21, the sensitivity and specificity were 85.6% and 84.8%, respectively. For the discrimination of category III from II or I, the ROC analyses showed that the AUC was 0.937 (95% CI 0.914-0.960). When using a cut-off point of 38 out of 39, the sensitivity and specificity were 85.8% and 87.1%, respectively (Table 2 ).
In the participants with diabetes mellitus (n = 70), the AUC was 0.934 (95% CI 0.871-0.997) for the discrimination of category I from II or III. When using a cut-off point of 26 out of 27, the sensitivity and specificity were 97.1% and 85.7%, respectively. For the discrimination of category III from II or I, the AUC was 0.944 (95% CI 0.886-1). When using a cut-off point of 38 out of 39, the sensitivity was 75.0% and the specificity was 91.9% (Table 3) . Table 4 shows the results of exploratory factor analyses for DASC-21. Three factors were extracted for cognitive function, IADL and BADL. In each factor, we selected items with a factor loading >0.8 and developed the DASC-8. The selected items for cognitive function were Q1 and Q4 (memory and orientation to time); Q10, Q11 and Q12 for IADL (shopping, use of transportation and money management); and Q18, Q20 and Q21 for BADL (toileting, eating and transferring; Appendix S2). The correlation between the DASC-21 and the DASC-8 was extremely high (r = 0.965, P < 0.001).
Development of the short version of the DASC-21
Reliability and discriminant validity of the DASC-8
The Cronbach's alpha of the DASC-8 was 0.900. For the discrimination of category I from II or III, the ROC analyses showed that the AUC was 0.909 (95% CI 0.882-0.936). When using a cut-off point of 10 out of 11 of the DASC-8, the sensitivity was 86.3% and the specificity was 81.6%. For the discrimination of category III from II or I, the ROC analyses showed that the AUC was 0.927 (95% CI 0.903-0.952). When using a cut-off point of 16 out of 17, the sensitivity was 85.2% and the specificity was 82.8% (Table 2 ). In participants with diabetes mellitus (n = 70), the AUC was 0.903 (95% CI 0.833-0.974) for the discrimination of category I from II or III. When using a cut-off point of 10 out of 11, the sensitivity was 93.4% and the specificity was 73.4%. The AUC was 0.928 (95% CI 0.851-1) for the discrimination of category III from II or I. When using a cut-off point of 16 out of 17, the sensitivity was 90.3% and the specificity was 75.0% (Table 3) .
Strength of association between the classification by the DASC score and that by the category operationally defined using the scores of the MMSE, Lawton IADL scale and Barthel Index Table 5 shows that using a cut-off of 26 out of 27 for the DASC-21 or 10 out of 11 for the DASC-8, category I was significantly discriminated from category II or III after adjusting for age and sex. After adjustment, the odds ratios were 26.1 (95% CI 14.60-46.70) and 22.5 (95% CI 12.60-40.00) for DASC-21 and DASC-8, respectively. When using a cut-off of 38 out of 39 for the DASC-21 or 16 out of 17 for the DASC-8, category III was significantly discriminated from category II or I after adjusting for age and sex. After adjustment, the odds ratios were 37.5 (95% CI 18.30-77.00) and 25.7 (95% CI 13.20-50.10) for DASC-21 and DASC-8, respectively.
Discussion
In the present study, the DASC-21 had sufficient reliability and validity to classify older people to the categories for determining the glycemic target based on cognitive and daily functions. The DASC-8, which is the shorter version of the DASC-21, had a strong correlation with the DASC-21, and also had sufficient reliability and validity. Similar results were also obtained in patients with diabetes. The Cronbach's alpha coefficients of the DASC-21 and the DASC-8 were excellent; therefore, their internal consistency was confirmed.
The MMSE, Lawton IADL scale and Barthel Index are well verified and widely used in Japan. [16] [17] [18] [19] In the current study, a strong correlation was observed between the DASC-21 and the MMSE, Lawton IADL scale and Barthel Index. Therefore, the DASC-21 has sufficient concurrent validity to assess both cognitive functions and ADL. Similar to the DASC-21, the DASC-8 also comprises three domains; namely, cognitive functions, IADL and BADL, and is strongly correlated with the MMSE, the Lawton IADL scale and the Barthel Index. It had good reliability and validity. These findings show that the DASC-8 is useful in evaluating cognitive function and ADL in a shorter time than the DASC-21, suggesting that it is more suitable for use in a fast-paced clinical setting. However, to improve the sensitivity for evaluating cognitive impairment, the assessment with the DASC-8 and DASC-21 should include assessments from family members and other supportive adults.
We previously reported that the DASC-21 also has a strong positive correlation with the Clinical Dementia Rating (CDR) total scores and the CDR box score. 10 The CDR is a widely used observational assessment tool for impairments in cognitive and daily functions, and can be used to assess the severity of dementia. 20 These results suggest that not only the DASC-21, but also the DASC-8 is useful for assessing the severity of dementia. The strength of this research is that this is the first validation study of the DASC21 and DASC-8 as an assessment tool for classifying patients to the category used for determining the glycemic target in older patients. Nevertheless, this research also had some limitations. First, the number of patients with diabetes mellitus was relatively small. Whether another evaluation method is necessary for diabetes patients is unknown. Second, the study participants were registered from just seven institutions, and the number of participants differed largely by institutions. Thus, there might have been some selection bias; therefore, there is need for caution in generalizing the results. However, participants were registered from multiple institutions covering a wide geographic area, and similar results were obtained by multiple logistic regression analysis after adjusting for institutions (Table S1 ). Thus, we believe that a certain degree of representativeness of the sample was achieved. Third, in the present study, intact cognitive function was defined based on the MMSE, but a previous study showed that dementia, particularly mild cognitive impairment, or the degree of dementia cannot be accurately diagnosed or evaluated based solely on the MMSE. 21 Using a more sensitive cognitive test, such as the Montreal Cognitive Assessment, might have yielded different cut-off values of the DASC-21 or DASC-8. Because the DASC-21 is also strongly correlated with the CDR, the DASC-21 or DASC-8 can be adequate for the simple and general assessment of cognitive and daily functions. For strict discrimination between normal cognition and mild cognitive impairment, the cut-off point might need to be modified. Third, we did not evaluate the test-retest reliability in the present study, which should be addressed in a future study.
Further studies are necessary to examine whether the DASC-21 or DASC-8 predicts functional and cognitive decline and mortality in a larger number of older patients with diabetes mellitus. Furthermore, we are planning to develop and verify a more simplified 2-point Likert scale assessment tool based on the DASC-8 for a more convenient usage.
In conclusion, due to the similar reliability and validity of the DASC-8 to the DASC 21, the DASC-8 can be used for determining glycemic targets based on cognitive and daily functions for older patients with diabetes, and thus is a convenient tool helpful for geriatric assessment.
